Page last updated: 2024-10-31

neostigmine and Thyrotoxicosis

neostigmine has been researched along with Thyrotoxicosis in 2 studies

Neostigmine: A cholinesterase inhibitor used in the treatment of myasthenia gravis and to reverse the effects of muscle relaxants such as gallamine and tubocurarine. Neostigmine, unlike PHYSOSTIGMINE, does not cross the blood-brain barrier.
neostigmine : A quaternary ammonium ion comprising an anilinium ion core having three methyl substituents on the aniline nitrogen, and a 3-[(dimethylcarbamoyl)oxy] substituent at position 3. It is a parasympathomimetic which acts as a reversible acetylcholinesterase inhibitor.

Thyrotoxicosis: A hypermetabolic syndrome caused by excess THYROID HORMONES which may come from endogenous or exogenous sources. The endogenous source of hormone may be thyroid HYPERPLASIA; THYROID NEOPLASMS; or hormone-producing extrathyroidal tissue. Thyrotoxicosis is characterized by NERVOUSNESS; TACHYCARDIA; FATIGUE; WEIGHT LOSS; heat intolerance; and excessive SWEATING.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
IRONSIDE, R1
Shrivastava, MP1
Datta, TK1
Madiajagne, R1

Other Studies

2 other studies available for neostigmine and Thyrotoxicosis

ArticleYear
Progressive exophthalmoplegia with muscular atrophy, myasthenia, and thyrotoxicosis.
    Proceedings of the Royal Society of Medicine, 1951, Volume: 44, Issue:8

    Topics: Humans; Hyperthyroidism; Muscles; Muscular Atrophy; Neostigmine; Oculomotor Muscles; Thyrotoxicosis

1951
Thyrotoxicosis with myasthenia--an unusual association.
    Journal of the Indian Medical Association, 1991, Volume: 89, Issue:9

    Topics: Adult; Blepharoptosis; Carbimazole; Female; Humans; Myasthenia Gravis; Neostigmine; Prednisolone; Th

1991